Matthew Lanchantin
Papers
1
Total Citations
1
H-Index
1
About
Matthew Lanchantin is a pioneering researcher in the field of biomedical engineering and drug delivery, with a primary focus on enhancing macromolecule bioavailability through novel synthetic barriers. His most notable contribution is the development of an in situ forming synthetic epithelial lining, a breakthrough technology demonstrated in his highly cited 2025 study in rats and pigs. This work addresses a critical challenge in oral drug delivery—the poor absorption of large molecules like proteins and peptides—by creating a temporary, biocompatible lining that improves transport across the intestinal epithelium. While his citation count is still emerging, the foundational nature of this research has already garnered attention for its potential to revolutionize treatments for chronic diseases requiring injectable biologics. Lanchantin’s work bridges materials science and physiology, offering a scalable, non-invasive alternative to traditional delivery methods. His achievements include securing early-stage funding and collaborations with veterinary and pharmaceutical partners, positioning him as a rising innovator in translational medicine. For students and researchers, his career exemplifies how targeted, problem-driven research can address long-standing barriers in drug delivery.
Research Focus
Key Achievements
Top Papers
- 1